HRP20090400T1 - Izokinolinski derivati - Google Patents

Izokinolinski derivati Download PDF

Info

Publication number
HRP20090400T1
HRP20090400T1 HR20090400T HRP20090400T HRP20090400T1 HR P20090400 T1 HRP20090400 T1 HR P20090400T1 HR 20090400 T HR20090400 T HR 20090400T HR P20090400 T HRP20090400 T HR P20090400T HR P20090400 T1 HRP20090400 T1 HR P20090400T1
Authority
HR
Croatia
Prior art keywords
isoquinolin
yloxy
piperidin
ylamine
alkyl
Prior art date
Application number
HR20090400T
Other languages
English (en)
Croatian (hr)
Inventor
Christopher Ray Peter
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36569955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20090400(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of HRP20090400T1 publication Critical patent/HRP20090400T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20090400T 2005-12-08 2006-12-06 Izokinolinski derivati HRP20090400T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05111813 2005-12-08
PCT/EP2006/069392 WO2007065916A1 (en) 2005-12-08 2006-12-06 Isoquinoline derivatives

Publications (1)

Publication Number Publication Date
HRP20090400T1 true HRP20090400T1 (hr) 2009-08-31

Family

ID=36569955

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090400T HRP20090400T1 (hr) 2005-12-08 2006-12-06 Izokinolinski derivati

Country Status (17)

Country Link
EP (1) EP1963304B2 (pl)
JP (1) JP5313682B2 (pl)
CN (1) CN101321748B (pl)
AR (1) AR058287A1 (pl)
AT (1) ATE434613T1 (pl)
CA (1) CA2629915C (pl)
CY (1) CY1110489T1 (pl)
DE (1) DE602006007488D1 (pl)
DK (1) DK1963304T3 (pl)
ES (1) ES2327677T3 (pl)
HR (1) HRP20090400T1 (pl)
PE (1) PE20070808A1 (pl)
PL (1) PL1963304T3 (pl)
PT (1) PT1963304E (pl)
SI (1) SI1963304T1 (pl)
TW (1) TW200738682A (pl)
WO (1) WO2007065916A1 (pl)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1899322B1 (en) 2005-06-28 2009-09-02 Sanofi-Aventis Isoquinoline derivatives as inhibitors of rho-kinase
ES2580108T3 (es) 2005-07-11 2016-08-19 Aerie Pharmaceuticals, Inc Compuestos de isoquinolina
SI1912949T1 (sl) 2005-07-26 2011-12-30 Sanofi Sa Cikloheksilamin izokinolonski derivati kot inhibitorji Rho-kinaze
PT1910333E (pt) * 2005-07-26 2013-08-01 Sanofi Sa Derivados de isoquinolona substituída com piperidinilo como inibidores da rho-cinase
ES2729424T3 (es) 2006-09-20 2019-11-04 Aerie Pharmaceuticals Inc Inhibidores de Rho cinasa
JP5313919B2 (ja) 2006-12-27 2013-10-09 サノフイ 新規な置換イソキノリン及びイソキノリノン誘導体
RU2457203C2 (ru) 2006-12-27 2012-07-27 Санофи-Авентис Замещенные циклоалкиламином производные изохинолона
AU2007338410B2 (en) 2006-12-27 2012-08-16 Sanofi-Aventis Cycloalkylamine substituted isoquinoline derivatives
JP5421783B2 (ja) * 2006-12-27 2014-02-19 サノフイ Ｒｈｏキナーゼ阻害剤としての置換イソキノロン及びイソキノリノン誘導体
PT2102164E (pt) 2006-12-27 2011-01-21 Sanofi Aventis Derivados de isoquinolina e de isoquinolinona substituída com cicloalquilamina
CA2673918C (en) * 2006-12-27 2015-02-17 Sanofi-Aventis Substituted isoquinoline and isoquinolinone derivatives
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
EP2240441B1 (en) * 2007-12-26 2015-06-03 Sanofi Process for the preparation of 6-substituted-1-(2h)-isoquinolinones
US8455514B2 (en) 2008-01-17 2013-06-04 Aerie Pharmaceuticals, Inc. 6-and 7-amino isoquinoline compounds and methods for making and using the same
JP5715561B2 (ja) 2008-06-24 2015-05-07 サノフイ 二及び多環式置換イソキノリン及びイソキノリノン誘導体
JP5713893B2 (ja) 2008-06-24 2015-05-07 サノフイ Ｒｈｏ−キナーゼ阻害剤としての置換イソキノリン類及びイソキノリノン類
JP5714485B2 (ja) 2008-06-24 2015-05-07 サノフイ ６−置換イソキノリン類及びイソキノリノン類
TW201006821A (en) * 2008-07-16 2010-02-16 Bristol Myers Squibb Co Pyridone and pyridazone analogues as GPR119 modulators
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
EP3828172A1 (en) 2009-05-01 2021-06-02 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
AU2012283335B2 (en) 2011-07-08 2016-09-01 Sanofi Substituted phenyl compounds
SI2729460T1 (sl) 2011-07-08 2016-05-31 Sanofi Kristalinični solvati 6-(piperidin-4-iloksi)-2H-izokinolin-1-on hidroklorida
AU2012283277B2 (en) 2011-07-08 2016-07-21 Sanofi Polymorphs of 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride
EP3141235A1 (en) 2012-12-06 2017-03-15 IP Gesellschaft für Management mbH N-(6-((2r,3s)-3,4-dihydroxybutan-2-yloxy)-2-(4-fluorobenzylthio)pyrimidin-4-yl)-3-methylazetidine-l -sulfonamide
US20140275160A1 (en) 2013-03-15 2014-09-18 Aerie Pharmaceuticals, Inc. Combination therapy
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
JP6832946B2 (ja) 2015-11-17 2021-02-24 アエリエ ファーマシューティカルズ インコーポレイテッド キナーゼ阻害剤およびその中間体の調製方法
CN109640966A (zh) 2016-08-31 2019-04-16 爱瑞制药公司 眼用组合物
TWI795381B (zh) 2016-12-21 2023-03-11 比利時商健生藥品公司 作為ｍａｌｔ１抑制劑之吡唑衍生物
WO2018183911A1 (en) 2017-03-31 2018-10-04 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
WO2018228452A1 (zh) * 2017-06-16 2018-12-20 成都先导药物开发有限公司 一种抑制 rock 的化合物及其用途
US11427563B2 (en) 2018-09-14 2022-08-30 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
CN113877483B (zh) * 2021-07-20 2023-11-24 烟台宁远药业有限公司 医药中间体卤代异喹啉类硼酸的低温连续合成装置与方法
EP4402129A1 (en) 2022-08-01 2024-07-24 Valo Health, Inc. <smallcaps/>? ? ?h? ? ? ? ?process for preparing 6-substituted-1-(2)-isoquinolinones and intermediate compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7199147B2 (en) * 2001-06-12 2007-04-03 Dainippon Sumitomo Pharma Co., Ltd. Rho kinase inhibitors
JPWO2004009555A1 (ja) * 2002-07-22 2005-11-17 旭化成ファーマ株式会社 ５−置換イソキノリン誘導体
EP1550660A1 (en) * 2002-09-12 2005-07-06 Kirin Beer Kabushiki Kaisha Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
PT1910333E (pt) * 2005-07-26 2013-08-01 Sanofi Sa Derivados de isoquinolona substituída com piperidinilo como inibidores da rho-cinase

Also Published As

Publication number Publication date
PL1963304T3 (pl) 2009-12-31
SI1963304T1 (sl) 2009-12-31
JP5313682B2 (ja) 2013-10-09
EP1963304B1 (en) 2009-06-24
EP1963304A1 (en) 2008-09-03
DK1963304T3 (da) 2009-10-12
AR058287A1 (es) 2008-01-30
ES2327677T3 (es) 2009-11-02
CN101321748B (zh) 2013-03-27
DE602006007488D1 (de) 2009-08-06
PT1963304E (pt) 2009-09-14
CY1110489T1 (el) 2015-04-29
CA2629915C (en) 2014-03-18
EP1963304B2 (en) 2015-05-13
CN101321748A (zh) 2008-12-10
ATE434613T1 (de) 2009-07-15
JP2009518360A (ja) 2009-05-07
TW200738682A (en) 2007-10-16
WO2007065916A1 (en) 2007-06-14
PE20070808A1 (es) 2007-08-27
CA2629915A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
AU2003252011B2 (en) Substituted 2-alkylamine nicotinic amide derivatives and use there of
JP5542336B2 (ja) 臨床的に潜伏性の微生物を死滅させるピロロキノリン化合物の使用
JP5183647B2 (ja) ４−ピリジルアルキルチオ基を置換基として有する新規化合物
CN109153650A (zh) 作为ehmt1和ehmt2抑制剂的胺取代的芳基或杂芳基化合物
AR035401A1 (es) El uso de compuestos derivados de feniletenilo y feniletinilo; compuestos derivados de feniletinilo; compuestos derivados de feniletenilo; un procedimiento para la elaboracion de los mismos; y medicamentos que los contienen
CA2853367A1 (en) New naphthyridine derivative compounds
EP2225223A2 (de) Organische verbindungen
JP2003503403A (ja) 呼吸合胞体ウイルス複製阻害剤
HRP20100153T1 (hr) Antagonisti kemokin receptora
WO2004020434A1 (ja) 含窒素芳香環誘導体
TW200738682A (en) Isoquinoline derivatives
SG186877A1 (en) Novel nicotinamide derivatives or salts thereof
EP2597955A1 (en) Quinoline derivatives and melk inhibitors containing the same
RU2006126663A (ru) Полициклические средства для лечения респираторно-синцитиальных вирусных инфекций
AU2015319724B2 (en) Novel soluble guanylate cyclase activators and their use
CN101300229A (zh) 作为胃酸分泌抑制剂的1-杂环基磺酰基、2-氨基甲基、5-(杂)芳基取代的1-h-吡咯衍生物
JP2007528394A5 (pl)
JP2021505598A5 (pl)
WO2016008593A1 (en) Novel substituted pyrimidine compounds
AR017189A1 (es) Antagonistas del receptor de trombina triciclico sustituido, composicion farmaceutica que lo contiene y su uso para la manufactura de un medicamento
NO20053730L (no) Pyridinderivater anvendelig for hemming av natrium/kalsium-utbyttingssystem
DE60209362D1 (de) 3-substituierte chinolin-4-carbonsäureamidderivate als nk-3- und nk-2-rezeptorantagonisten
RU2006125726A (ru) Аминобензимидазолы и бензимидазолы в качестве ингибиторов репликации респираторно-синцитиального вируса
CA2378834A1 (en) Pyrazinones, compositions containing such compounds
CN120136869A (zh) 三环稠杂环类pde3/4双重抑制剂及其制备方法与应用